Session Information
ENDO 2010 Annual Meeting - Includes 5 Complimentary Sessions
Click here to go to the previous page
CLINICAL - Neuroendocrine Dysfunction & Psychoactive Drugs
Track
:
CLINICAL
Program Code:
S20
Date:
Saturday, June 19, 2010
Time:
3:45 PM to 5:15 PM
EST
Location:
33ABC
SPEAKER
(S):
John W. Newcomer, MD, Washington Univ Sch of Med, St Louis, MO
Disclosure: Consultant, AstraZeneca, Jansen Pharmaceuticals, Organon Laboratories, Pfizer, Inc., Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, Bristol-Myers Squibb, H. Lundbeck, Otsuka Pharmaceuticals, Vanda Pharmaceutical, DSMC Member, Organon Laboratories, Schering Plough, Vivus USA, Dainippon Sumitomo Pharma America, Inc.; Data Safety Monitoring Committee Compact Clinicals, Vivus, Inc.; Product Development, Jones and Bartlett Publishing.
Disclosure: Consultant, AstraZeneca, Jansen Pharmaceuticals, Organon Laboratories, Pfizer, Inc., Solvay Pharmaceuticals, Inc., Wyeth Pharmaceuticals, Bristol-Myers Squibb, H. Lundbeck, Otsuka Pharmaceuticals, Vanda Pharmaceutical, DSMC Member, Organon Laboratories, Schering Plough, Vivus USA, Dainippon Sumitomo Pharma America, Inc.; Data Safety Monitoring Committee Compact Clinicals, Vivus, Inc.; Product Development, Jones and Bartlett Publishing.
Janet A. Schlechte, MD, Univ of Iowa, Iowa City, IA
Disclosure: Nothing to Disclose
Disclosure: Nothing to Disclose
No items are available for this session.